Discovery of Small Molecule NSC290956 as a Therapeutic Agent for KRas Mutant Non-Small-Cell Lung Cancer
HRas-GTP has a transient intermediate state with a "non-signaling open conformation" in GTP hydrolysis and nucleotide exchange. Due to the same hydrolysis process and the structural homology, it can be speculated that the active KRas adopts the same characteristics with the "open conf...
Saved in:
Main Authors: | Jiaxin Zhang (Author), Zuojia Liu (Author), Wenjing Zhao (Author), Xunzhe Yin (Author), Xiliang Zheng (Author), Chuanbo Liu (Author), Jin Wang (Author), Erkang Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective
by: Wenyue Zheng, et al.
Published: (2022) -
Small molecule drug discovery targeting the JAK-STAT pathway
by: You Lv, et al.
Published: (2024) -
Discovery of a small-molecule NDR1 agonist for prostate cancer therapy
by: Yang Bai, et al.
Published: (2024) -
In silico analysis of wild-type and mutant KRAS
by: Frengki Frengki, et al.
Published: (2019) -
Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
by: Wenjing Xiao, et al.
Published: (2021)